@article{720837,
      author = {Olson, Steve, and Claiborne, Anne B.,},
      url = {http://library.usi.edu/record/720837},
      title = {Maximizing the impact of the Cures Acceleration Network  accelerating the development of new drugs and diagnostics :  workshop summary / [electronic resource] :},
      abstract = {Advances in technologies and knowledge are creating new  avenues for research and opportunities for the discovery  and clinical development of innovative therapies and  diagnostics. However, despite these opportunities, only a  small fraction of investigational products are successfully  developed into cures and therapies that can be accessed by  patients. One response to the ever-widening gap between the  number and promise of basic scientific discoveries and the  translation of those discoveries into therapies is a  renewed emphasis on collaborative approaches among federal  agencies, academia, and industry, all directed at the  advancement of the drug development enterprise. The newly  developed Cures Acceleration Network (CAN)-a part of the  National Center for Advancing Translational Sciences  (NCATS) within the National Institutes of Health (NIH)-has  the potential to catalyze widespread changes in NCATS, NIH,  and the drug development ecosystem in general. On June 4-5,  2012, the IOM Forum on Drug Discovery, Development, and  Translation held, at the request of NCATS, a  workshop-bringing together members of federal government  agencies, the private sector, academia, and advocacy  groups-to explore options and opportunities in the  implementation of CAN. Accelerating the Development of New  Drugs and Diagnostics: Maximizing the Impact of the Cures  Acceleration Network: Workshop Summary summarizes the  workshop."--Publisher's description.},
      recid = {720837},
      pages = {1 online resource (131 pages)},
}